Mechanisms Supporting Psilocybin-assisted Psychotherapy for Alcohol Use Disorder: A Randomized, Controlled Clinical Trial
The aim of this study is to determine if a single dose of psilocybin administered with motivational enhancement therapy (MET) can reduce heavy drinking in patients with an alcohol use disorder (AUD).
- Status
- recruiting
- Phase
- Phase 2
- Institution
- University of Calgary
- Principal investigator
- Leah Mayo, PhD
- Start date
- 2024-03-20
- End date
- 2027-10-01
- Registry ID
- NCT05995769
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.